Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000721748-13-000915
Filing Date
2013-12-12
Accepted
2013-12-12 17:05:30
Documents
5
Period of Report
2013-11-30

Document Format Files

Seq Description Document Type Size
1 finalgbiq10ka113012.htm 10-K/A 403467
2 CERTIFICATIONS gbiq311.htm EX-31.1 9698
3 CERTIFICATIONS gbiq312.htm EX-31.2 9487
4 GRAPHIC image_002.gif GRAPHIC 73
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER gbiq321.htm EX-32 3876
  Complete submission text file 0000721748-13-000915.txt   427857
Mailing Address 2711 CENTERVILLE SUITE 400 WILMINGTON DE 19808
Business Address 2550 BATES RD. SUITE 212 MONTREAL A8 H3S 1A7 302 288 0658
Global Biotech Corp. (Filer) CIK: 0001126162 (see all company filings)

EIN.: 980229951 | Fiscal Year End: 0228
Type: 10-K/A | Act: 34 | File No.: 000-33271 | Film No.: 131274167
SIC: 7389 Services-Business Services, NEC